What Has Been the Progress and Growth of the Injectable Drug Delivery Devices Market in Recent Years?
The injectable drug delivery devices market has seen considerable growth due to a variety of factors.
• The rapid expansion of the injectable drug delivery devices market in recent years is remarkable, with projections of it rising from $49.59 billion in 2024 to $54.67 billion in 2025. This translates to a compound annual growth rate (CAGR) of 10.3%.
Factors contributing to the noteworthy growth during the historical period include a surging elderly population, increase in the number of healthcare establishments, elevated healthcare spending, progression in biologics, and heightened awareness around self-administration.
What Can Be Expected from the Injectable Drug Delivery Devices Market in the Coming Years?
The injectable drug delivery devices market is expected to maintain its strong growth trajectory in upcoming years.
• There is a prediction of solid expansion in the injectable drug delivery devices market size in the forthcoming years. The market value is anticipated to surge up to $75.28 billion in 2029 with an 8.3% compound annual growth rate (CAGR).
This projected expansion throughout the forecast period is linked to a rising incidence of chronic ailments, a surge in injectable drug demands, an unexpected onset of acute infections, and a massive amount of drugs and vaccines in various clinical trial stages. Key trends during the forecast period include a concentration on developing microneedle-based drug delivery systems, investment in R&D of self-injectable devices, manufacturing wearable devices, needle-free injection systems, broadening the product line with prefilled syringes, improving their devices' digital technology, producing innovative devices and auto-injectors.
What Are the Critical Driver Fuelling the Injectable Drug Delivery Devices Market's Growth?
The surge in preference for self-injection devices propels the market for injectable drug delivery devices. Essentially, self-injection devices are medical tools that patients can utilize on their own in a home-based setting for self-medication. They range from needle-free to auto, pen, and wearable injectors. These self-injectable units are designed to be the most flexible, providing accurate drug delivery and ease of use. Furthermore, advancements in the self-injectable apparatus have widened their acceptance over recent years. Becton, Dickinson, and Company produce BD Physioject, a disposable auto-injector specifically intended for self-injection of drugs by chronically ill patients, such as those with rheumatoid arthritis, multiple sclerosis, asthma, and osteoporosis. It has been clinically tested, proven dependable, and cost-effective. Other entities engaged in the self-injections market include the likes of AbbVie, Inc., 3M, Baxter, Gerresheimer AG, Pfizer Inc., among others. Beyond the inherent benefits of self-injectable injections, increased education on self-administration has boosted demand for these self-injectable tools, set to spur the injectable drug delivery devices market throughout the prediction period.
How Is the Injectable Drug Delivery Devices Market segmented?
The injectable drug delivery devices market covered in this report is segmented –
1) By Type: Syringes, Injectors And Pump
2) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
3) By End-user: Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users
Subsegments:
1) By Syringes: Conventional Syringes, Prefilled Syringes, Safety Syringes
2) By Injectors: Autoinjectors, Pen Injectors, Needle-Free Injectors
3) By Pumps: Insulin Pumps, Ambulatory Infusion Pumps, Implantable Pumps
Pre-Book The Injectable Drug Delivery Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing the Injectable Drug Delivery Devices Market?
The industry of injectable drug delivery systems is progressively shifting its focus towards the construction of auto-injectors. Fully automated, extensively personalized, and recyclable auto-injectors are now a key product; they're capable of performing hundreds of injections and can be operated by the patient themselves. The delivery speed of the dose is controllable by the patient, reducing pain or distress during the injection. These tools allow automatic injection speed and depth modification. For example, Unilife Corporation's LISA, a reusable auto-injector, is highly adaptable with features such as Bluetooth LE connectivity, Wi-Fi or 3G connectivity, and pre-injection drug heating for targeted therapies. The injectable drug delivery tech market anticipates substantial growth in future years due to continuous technological progress and the introduction of new products, thus heightening the convenience and simplicity of administering parenteral therapeutics.
Who Are the Key Players in the Injectable Drug Delivery Devices Market?
Major companies operating in the injectable drug delivery devices market include:
• Becton
• Dickinson and Company
• Baxter International
• Gerresheimer AG
• Catalent. Inc.
• SkyePharma PLC
• Antares Pharma
• Pfizer Inc
• GE Healthcare
• Owen Mumford
• Catalent Pharma Solutions
• Philips
• West Pharmaceutical Services. Inc.
• Alkermes
• Schott AG
• UCB
• AstraZeneca
• Johnson & Johnson
• NEARMEDIC PLUS LLC
• Pendant Biosciences
• Siemens
• H&T Presspart
• B Braun
• Copernicus
• Ypsomed AG
• 3M Company
• Aptar
• Congenica Ltd.
• Julphar
• Nemera
• Stryker
• Roche
• Nektar Therapeutics
• Eli Lilly
• Merck & Co. Inc.
• Sandoz
• Sorrel Medical
• Teleflex Medical
• Gilero
• Teva Pharmaceutical Industries Ltd.
• GlaxoSmithKline
• MediPrint Ophthalmics
• Medtronic
• Novartis
• Pharmasyntez
• Bayer
• Mylan N.V
• Aptalis Pharma. Inc.
• Sanofi
• Novo Nordisk
• Bilim Pharmaceuticals
• Battelle Medical Devices
• Caplin Steriles Limited
• Abbot
• Allergan
• Boehringer Ingelheim
• Hovione Technology
• Jiangsu Delfu Medical Device Co. Ltd.
• Syqe Medical
• Terumo Corporation
• Kedalion Therapeutics
• Amgen Inc.
What Is The Most Dominant Region In The Injectable Drug Delivery Devices Market?
North America was the largest region in the injectable drug delivery devices market in 2024. Western Europe was the second-largest region in the global injectable drug delivery devices market. The regions covered in the injectable drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
